AIM ImmunoTech Inc. (AIM)
AMEX·Healthcare·Biotechnology
$0.52
+0.81%
Mkt Cap $2.47M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 27, 2026 | $100.00K | $21.00K | -79.00% | -$0.94 | -$0.44 | +53.19% | — | — |
| Q4 2025 Nov 17, 2025 | — | $26.00K | — | -$0.97 | -$1.57 | -61.02% | — | — |
| Q3 2025 Aug 14, 2025 | $100.00K | $25.00K | -75.00% | -$8.00 | -$3.68 | +54.00% | — | — |
| Q2 2025 May 15, 2025 | — | $16.00K | — | -$8.00 | -$5.00 | +37.50% | — | — |
| Q1 2025 Mar 27, 2025 | $100.00K | $45.00K | -55.00% | -$9.00 | -$10.00 | -11.11% | — | — |
| Q4 2024 Nov 14, 2024 | $100.00K | $35.00K | -65.00% | -$10.00 | -$6.00 | +40.00% | — | — |
| Q3 2024 Aug 14, 2024 | $10.00K | $50.00K | +400.00% | -$0.12 | -$3.00 | -2400.00% | — | — |
| Q2 2024 May 16, 2024 | — | $40.00K | — | -$0.11 | -$12.00 | -10809.09% | — | — |
| Q1 2024 Mar 29, 2024 | $40.00K | $65.00K | +62.50% | -$0.15 | -$26.00 | -17233.33% | — | — |
| Q4 2023 Nov 14, 2023 | $40.00K | $46.00K | +15.00% | -$0.11 | -$16.00 | -14445.45% | — | — |
| Q3 2023 Aug 15, 2023 | $20.00K | $42.00K | +110.00% | -$0.11 | -$10.00 | -8990.91% | — | — |
| Q2 2023 May 12, 2023 | — | $49.00K | — | -$0.11 | -$8.00 | -7172.73% | — | — |
| Q2 2023 Apr 3, 2023 | $180.00K | $56.00K | -68.89% | -$0.12 | -$9.00 | -7400.00% | — | — |
| Q4 2022 Nov 15, 2022 | $180.00K | $21.00K | -88.33% | -$0.08 | -$13.00 | -16150.00% | — | — |
| Q3 2022 Aug 15, 2022 | $137.67K | $30.00K | -78.21% | -$0.07 | -$10.00 | -14185.71% | — | — |
| Q2 2022 May 16, 2022 | $100.00K | $33.00K | -67.00% | -$0.07 | -$8.00 | -11328.57% | — | — |
| Q1 2022 Mar 31, 2022 | $36.67K | $50.00K | +36.36% | -$0.08 | -$12.00 | -14900.00% | — | — |
| Q4 2021 Nov 16, 2021 | $350.00K | $33.00K | -90.57% | -$0.07 | -$8.00 | -11328.57% | — | — |
| Q3 2021 Aug 17, 2021 | $350.00K | $23.00K | -93.43% | — | -$12.00 | — | — | — |
| Q2 2021 May 18, 2021 | $31.11K | $28.00K | -10.00% | -$0.09 | -$8.00 | -8788.89% | — | — |